Quote:
Originally Posted by Sephiroth
[COLOR="Blue"]
I refer you to my reply to Hugh. Multiple production sites that were not yet available at contract signing is a great red flag to the likes of me and no mitigation at all.
The portfolio approach yielded little as well.
Why are you defending those fools (again)?
|
No sites were available to anyone in August when they contracted with AstraZeneca for an unproven vaccination. I'm sure Norway, Iceland, EU, UK, etc all understood the risks.
Jonbxx has neatly explained the processes. I hope that when you have had time to reflect upon his posts, you will be able to adjust your your perspectives to fully appreciate his insight.
(But we'd both better avoid going backwards and forwards too much as we'll bore the forum.
)